Mounting Challenges for Simulations Plus as Legal and Financial Pressures Intensify

The biosimulation company Simulations Plus finds itself navigating the most turbulent period in its recent history. A combination of legal scrutiny, disappointing financial performance, and potential removal from a major stock index has created a perfect storm for the once-promising firm.

The current difficulties began with a series of disappointing financial announcements. On June 11, 2025, preliminary third-quarter results fell short of market expectations, triggering an immediate 24% decline in share value. When the company released its final report on July 14, the situation worsened considerably. Despite recording modest revenue growth, Simulations Plus significantly missed consensus estimates, leading to another dramatic selloff that erased 25.75% of the company’s market value.

Legal Investigations Compound Problems

Within weeks of the financial disclosures, Simulations... Read more...